Dexlansoprazole
Brand name: Dexlansoprazole Dr
Rank #162 of 500 drugs by total cost
$98.7M
Total Cost
275,116
Total Claims
$98.7M
Total Cost
9,884
Prescribers
$359
Cost per Claim
26,262
Beneficiaries
418,402
30-Day Fills
$9,985
Avg Cost/Provider
28
Avg Claims/Provider
About Dexlansoprazole
Dexlansoprazole (sold as Dexlansoprazole Dr) was prescribed 275,116 times by 9,884 Medicare Part D providers in 2023, costing the program $98.7M. At $359 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 159 | Tocilizumab (Actemra) | $99.5M | 24,891 |
| 160 | Omalizumab (Xolair) | $98.9M | 30,451 |
| 161 | Brimonidine Tartrate (Alphagan P) | $98.8M | 988,570 |
| 162 | Dexlansoprazole (Dexlansoprazole Dr) | $98.7M | 275,116 |
| 163 | Interferon Beta-1a (Avonex) | $98.3M | 11,314 |
| 164 | Guselkumab (Tremfya) | $97.1M | 7,102 |
| 165 | Levetiracetam (Levetiracetam) | $96.1M | 1,723,736 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology